kisd@ifj.edu.pl (+48) 12 662 8344

Research topics – IF PAN

The field of medical and health sciences, the discipline of medical sciences

List of research topics with details in Polish and English:

No.Research topicCandidate for doctoral supervisor
1The assessment of neuroprotective and neuroregenerative potential of new low-basicity 5-HT7 receptor agonists- in vitro studies (details)  Dr hab. Danuta Jantas
2The role of glia and its activation in the processes of regeneration and compensation of nigrostriatal system degeneration (details)Dr hab. Katarzyna Kuter
3Molecular profiling of novel antipsychotic drug candidates (details)Dr hab. Jan Rodriguez Parkitna
4The role of cognitive bias in individual vulnerability to the transition from controlled use to uncontrolled abuse of alcohol in an animal model (details)Dr hab. Rafał Ryguła
5The neuroprotective role of new steroid and xenobiotic receotors ligands in the protection of mammalian brain neuronal cells against neurodegeneration (details)Prof. dr hab. Małgorzata Kajta/ dr Agnieszka Wnuk
6Significance of glutamatergic NMDA receptors in the regulation of liver cytochrome P450 (details)Prof. dr hab. Władysława Anna Daniel
7Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice (details)Dr hab. Bernadeta Szewczyk/ dr Bartłomiej Pochwat
8Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligands as a novel efficacious method to treat depression – the preclinical studies (details)Prof. dr hab. Andrzej Pilc
9Novel biased opioid receptor agonists for treatment of opioid use disorder (details)Prof. dr hab. Ryszard Przewłocki
10Endocannabinoid regulation of the motivational tone at the mesolimbic system driven by inflammation (details)Dr hab. Katarzyna Starowicz-Bubak, prof. IF PAN
11Role of intracellular signaling pathways linked with activation of the ghrelin receptor and RET tyrosine kinase in neuroprotection of catecholaminergic (details)  Dr hab. Grzegorz Kreiner/ dr Piotr Chmielarz
12Molecular characterization of habenular nuclei in a genetic model of drug resistance depression (details)Dr hab. Agata Faron-Górecka
13In silico polypharmacology in neurodegenerative diseases – searching for new molecular targets and antitargets (details)Dr hab. Rafał Kurczab
14New experimental electron density-based scoring functions for molecular docking (details)Dr hab. Rafał Kurczab
15Evaluation of biocompatibility and neuroprotective properties of drug-loaded theranostic nanocarriersfor treatment of brain ischemia (details)Prof. dr hab. Władysław Lasoń